Strides Arcolab has informed about a fire accident at Cuddalore facility made by Shasun Pharmaceuticals, which merged with the Company with effect from November 19, 2015. The Company has now informed the Exchange that the Cuddalore facility has been permitted to resume operations in all manufacturing production blocks except the new production block. The Company confirms that there will not be any material impact on the revenue of the Group during the current financial year.
The above information is a part of company’s filings submitted to BSE.
